Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISM: Sildenafil during labor in low-resource settings
NCT06377098Phase 3Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of ASP-001 in Non-reassuring fetal status (NRFHT), perinatal asphyxia, sponsored by University of Alabama at Birmingham. Planned start May 2025; status: withdrawn.
02
Drugs
ASP-001
03
Conditions
Non-reassuring fetal status (NRFHT)perinatal asphyxia
Beyond the preview
Go deeper on NCT06377098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06377098.